1376 related articles for article (PubMed ID: 9485189)
1. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
[TBL] [Abstract][Full Text] [Related]
2. Differential modulation of immune recognition molecules by interleukin-7 in human acute leukaemias.
Costello RT; Mallet F; Chambost H; Sainty D; Gastaut JA; Olive D
Eur Cytokine Netw; 1999 Mar; 10(1):87-96. PubMed ID: 10210778
[TBL] [Abstract][Full Text] [Related]
3. Decreased inducible expression of CD80 and CD86 in human monocytes after ultraviolet-B irradiation: its involvement in inactivation of allogenecity.
Fujihara M; Takahashi TA; Azuma M; Ogiso C; Maekawa TL; Yagita H; Okumura K; Sekiguchi S
Blood; 1996 Mar; 87(6):2386-93. PubMed ID: 8630402
[TBL] [Abstract][Full Text] [Related]
4. Regulation of CD40 ligand expression on naive CD4 T cells: a role for TCR but not co-stimulatory signals.
Jaiswal AI; Dubey C; Swain SL; Croft M
Int Immunol; 1996 Feb; 8(2):275-85. PubMed ID: 8671613
[TBL] [Abstract][Full Text] [Related]
5. Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas.
Chaperot L; Plumas J; Jacob MC; Bost F; Molens JP; Sotto JJ; Bensa JC
Exp Hematol; 1999 Mar; 27(3):479-88. PubMed ID: 10089910
[TBL] [Abstract][Full Text] [Related]
6. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
[TBL] [Abstract][Full Text] [Related]
7. A T cell lymphoma can provide potent co-stimulatory effects to T cells that are not mediated by B7-1, B7-2, CD40, HSA or CD70.
Nieland JD; Kruisbeek AM
Int Immunol; 1995 Nov; 7(11):1827-38. PubMed ID: 8580081
[TBL] [Abstract][Full Text] [Related]
8. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
[TBL] [Abstract][Full Text] [Related]
9. Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells.
Decker T; Schneller F; Sparwasser T; Tretter T; Lipford GB; Wagner H; Peschel C
Blood; 2000 Feb; 95(3):999-1006. PubMed ID: 10648415
[TBL] [Abstract][Full Text] [Related]
10. Expression of co-stimulatory molecules on acute myeloid leukaemia blasts may effect duration of first remission.
Whiteway A; Corbett T; Anderson R; Macdonald I; Prentice HG
Br J Haematol; 2003 Feb; 120(3):442-51. PubMed ID: 12580958
[TBL] [Abstract][Full Text] [Related]
11. FcR cross-linking on monocytes results in impaired T cell stimulatory capacity.
Barcy S; Wettendorff M; Leo O; Urbain J; Kruger M; Ceuppens JL; de Boer M
Int Immunol; 1995 Feb; 7(2):179-89. PubMed ID: 7537534
[TBL] [Abstract][Full Text] [Related]
12. Cryptococcus neoformans differently regulates B7-1 (CD80) and B7-2 (CD86) expression on human monocytes.
Vecchiarelli A; Monari C; Retini C; Pietrella D; Palazzetti B; Pitzurra L; Casadevall A
Eur J Immunol; 1998 Jan; 28(1):114-21. PubMed ID: 9485191
[TBL] [Abstract][Full Text] [Related]
13. Differential requirements for expression of CD80/86 and CD40 on B cells for T-dependent antibody responses in vivo.
Lumsden JM; Williams JA; Hodes RJ
J Immunol; 2003 Jan; 170(2):781-7. PubMed ID: 12517941
[TBL] [Abstract][Full Text] [Related]
14. Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood monocytes.
Fleischer J; Soeth E; Reiling N; Grage-Griebenow E; Flad HD; Ernst M
Immunology; 1996 Dec; 89(4):592-8. PubMed ID: 9014827
[TBL] [Abstract][Full Text] [Related]
15. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN
Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
[TBL] [Abstract][Full Text] [Related]
16. The role of T cell costimulation by CD80 in the initiation and maintenance of the immune response to human leukemia.
Matsumoto K; Anasetti C
Leuk Lymphoma; 1999 Nov; 35(5-6):427-35. PubMed ID: 10609780
[TBL] [Abstract][Full Text] [Related]
17. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal.
Ranheim EA; Kipps TJ
J Exp Med; 1993 Apr; 177(4):925-35. PubMed ID: 7681471
[TBL] [Abstract][Full Text] [Related]
18. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7-1) expression.
Ozawa H; Aiba S; Nakagawa ; Tagami H
Eur J Immunol; 1996 Mar; 26(3):648-52. PubMed ID: 8605933
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of B7 co-stimulatory molecules by astrocytes correlates with T cell activation and cytokine production.
Soos JM; Ashley TA; Morrow J; Patarroyo JC; Szente BE; Zamvil SS
Int Immunol; 1999 Jul; 11(7):1169-79. PubMed ID: 10383950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]